<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">The T H 1 phenotype of follicular helper T cells indicates an IFN-g-associated immune dysregulation in patients with CD21low common variable immunodeficiency</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><roleName>MSc</roleName><forename type="first">Susanne</forename><surname>Unger</surname></persName>
							<affiliation key="aff2">
								<orgName type="department" key="dep1">Faculty of Biology</orgName>
								<orgName type="department" key="dep2">Department of Otorhi-nolaryngology-Head and Neck Surgery</orgName>
								<orgName type="department" key="dep3">Institute for Sur-gical Pathology</orgName>
								<orgName type="department" key="dep4">Department of Rheumatology and Clinical Immunology</orgName>
								<orgName type="institution">University of Freiburg</orgName>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department" key="dep1">Department of Immunology</orgName>
								<orgName type="department" key="dep2">Depart-ment of Pediatrics</orgName>
								<orgName type="institution" key="instit1">University Medical Center Freiburg</orgName>
								<orgName type="institution" key="instit2">Erasmus MC</orgName>
								<orgName type="institution" key="instit3">University Medical Center Rotterdam</orgName>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Maximilian</forename><surname>Seidl</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Pauline</forename><surname>Van Schouwenburg</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Mirzokhid</forename><surname>Rakhmanov</surname></persName>
							<affiliation key="aff4">
								<orgName type="department">Depart-ment of Internal Medicine 3-Rheumatology and Immunology</orgName>
								<orgName type="laboratory">the Center for Human Genetics and Laboratory Diagnostics (AHC)</orgName>
								<orgName type="institution">Universit€ atsklinikum Erlangen</orgName>
								<address>
									<settlement>Martinsried</settlement>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="department">Insti-tute of Medical Immunology</orgName>
								<orgName type="institution">Friedrich-Alexander-Universit€ at Erlangen-N€ urnberg</orgName>
								<address>
									<settlement>Erlangen</settlement>
								</address>
							</affiliation>
							<affiliation key="aff6">
								<orgName type="institution">Charit e University Medicine Berlin</orgName>
								<address>
									<addrLine>Campus Virchow</addrLine>
									<settlement>Berlin</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Alla</forename><surname>Bulashevska</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Natalie</forename><surname>Frede</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Bodo</forename><surname>Grimbacher</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Jens</forename><surname>Pfeiffer</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Klaudia</forename><surname>Schrenk</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Luis</forename><surname>Munoz</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Leif</forename><surname>Hanitsch</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Ina</forename><surname>Stumpf</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Fabian</forename><surname>Kaiser</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Oliver</forename><surname>Hausmann</surname></persName>
							<affiliation key="aff7">
								<orgName type="institution">L€ owenpraxis and Klinik St Anna</orgName>
								<address>
									<region>Luzern</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Florian</forename><surname>Kollert</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Sigune</forename><surname>Goldacker</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Mirjam</forename><surname>Van Der Burg</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Baerbel</forename><surname>Keller</surname></persName>
						</author>
						<author role="corresp">
							<persName><roleName>MD</roleName><forename type="first">Klaus</forename><surname>Warnatz</surname></persName>
							<email>klaus.warnatz@uniklinik-freiburg.de.</email>
						</author>
						<author>
							<affiliation key="aff0">
								<address>
									<settlement>Freiburg, Martinsried, Erlangen, Berlin, Rotterdam, Luzerne</settlement>
									<country>Germany, The Netherlands, Switzerland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Center for Chronic Immunodeficiency (CCI)</orgName>
								<orgName type="department" key="dep2">Medical Center</orgName>
								<orgName type="department" key="dep3">Faculty of Medicine</orgName>
								<orgName type="institution">University of Freiburg</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff8">
								<orgName type="institution">UKL-FR and University College London</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff9">
								<orgName type="department">Medical Center</orgName>
								<orgName type="institution" key="instit1">University of Freiburg Cen-ter for Chronic Immunodeficiency</orgName>
								<orgName type="institution" key="instit2">CCI</orgName>
								<address>
									<addrLine>Breisacher Str 115</addrLine>
									<postCode>79106</postCode>
									<settlement>Freiburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">The T H 1 phenotype of follicular helper T cells indicates an IFN-g-associated immune dysregulation in patients with CD21low common variable immunodeficiency</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">1BAAB5BCA847594D0052FA98933CC0E5</idno>
					<idno type="DOI">10.1016/j.jaci.2017.04.041</idno>
					<note type="submission">received a grant from ZonMW Veni (91616058). N. Frede has received royalties from Oxford University Press and Cambridge University Press and has received travel support from CSL Behring. B. Grimbacher has received grants from the Federal Ministry of Education Received for publication November 30, 2016; revised March 31, 2017; accepted for publication April 12, 2017. Available online May 26, 2017.</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:25+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>Follicular helper T cells</term>
					<term>common variable immunodeficiency</term>
					<term>IFN-g</term>
					<term>germinal center</term>
					<term>CD21 low B cells</term>
					<term>T-bet</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Background: A subgroup of patients with common variable immunodeficiency (CVID) experience immune dysregulation manifesting as autoimmunity, lymphoproliferation, and organ inflammation and thereby increasing morbidity and mortality.</s><s>Therefore treatment of these complications demands a deeper comprehension of their cause and pathophysiology.</s><s>Objectives: On the basis of the identification of an interferon signature in patients with CVID with secondary complications and a skewed follicular helper T-cell differentiation in defined monogenic immunodeficiencies, we sought to determine the profile of CD4 memory T cells in blood and secondary lymphatic tissues of these patients.</s></p><p><s>Methods: We quantified T H 1/T H 2/T H 17 CD4 memory T cells in blood and lymph nodes of patients with CVID using flow cytometry, analyzed their function, and correlated all findings to the burden of immune dysregulation.</s><s>Results: Patients with CVID with immune dysregulation had a skewed memory CD4 T-cell differentiation toward a CXCR3 1 CCR6 2 T H 1 phenotype both in blood and lymph nodes.</s><s>Consistent with our phenotypic findings, we observed a higher IFN-g production in peripheral CD4 memory T cells and lymph node-derived follicular helper T cells of patients with CVID compared with those of healthy control subjects.</s><s>Increased IFN-g production was accompanied by a poor germinal center output, an accumulation of T-box transcription factor (T-bet) 1 B cells in lymph nodes, and an accumulation of T-bet 1 CD21 low B cells in peripheral blood of affected patients.</s><s>Conclusion: Identification of excessive IFN-g production by blood and lymph node-derived T cells of patients with CVID with immune dysregulation will offer new therapeutic avenues for this subgroup.</s><s>CD21 low B cells might serve as a marker of this IFN-g-associated dysregulation.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Common variable immunodeficiency (CVID) comprises a heterogeneous group of disorders of hypogammaglobulinemia (www.esid.org).</s><s>Based on their clinical presentation, they can be divided into patients who present only with infections (common variable immunodeficiency with only infectious complications [CVIDio]) and those who are additionally affected by various manifestations of immune dysregulation (complex common variable immunodeficiency [CVIDc]), including autoimmune cytopenia, lymphadenopathy, granulomatous disease, interstitial lung disease, and enteropathy, contributing to an increased morbidity and mortality in this frequent subgroup (30% to 50% of patients). <ref type="bibr" target="#b0">1,</ref><ref type="bibr" target="#b1">2</ref></s><s>Regular immunoglobulin replacement therapy significantly reduces the number and severity of bacterial infections but has little effect on immune dysregulation. <ref type="bibr" target="#b2">3</ref></s><s>herefore patients often receive nonspecific immunosuppressive treatment, potentially aggravating the already impaired host defense.</s><s>A deeper comprehension of the underlying cause and pathophysiology of the disease in patients with CVIDc is highly warranted.</s></p><p><s>In patients with monogenic immunodeficiencies presenting like CVIDc, we have recently seen a skewed differentiation of CD4 1 CXCR5 1 circulating follicular helper T (cTFH) cells toward a T H 1-like phenotype. <ref type="bibr" target="#b3">4</ref></s><s>cTFH cells correlate with tissue follicular helper T (TFH) cells regarding gene expression profile and superior capacity to support antibody production by B cells. <ref type="bibr" target="#b4">5,</ref><ref type="bibr" target="#b5">6</ref></s><s>They can be delineated into cTFH1, cTFH1/17, cTFH2, and cTFH17 cells with similar master transcription factors, signature cytokines, and chemokine receptor profiles as their non-cTFH counterparts. <ref type="bibr" target="#b3">4</ref></s><s>For example, patients with gain-offunction mutations in signal transducer and activator of transcription 1 (STAT1) or STAT3 present with a relative expansion of CXCR3 1 CCR6 2 T H 1-like cTFH cells.</s><s>Based on these findings and recent whole-blood transcriptional profiling that revealed that patients with CVIDc are characterized by a marked upregulation of interferon-responsive genes, <ref type="bibr" target="#b6">7</ref> we wondered whether a similar shift of cTFH cells and subsequent increased IFN-g production is present in genetically undefined patients with CVIDc.</s></p><p><s>Interferon gene signatures of peripheral blood cells have also previously been described in patients with systemic lupus erythematosus, <ref type="bibr" target="#b7">8</ref> arising from increased type I and II interferon exposure. <ref type="bibr" target="#b8">9,</ref><ref type="bibr" target="#b9">10</ref></s><s>In a mouse model of lupus, excessive IFN-g was responsible for the accumulation of TFH cells in the germinal center (GC) and autoantibody formation. <ref type="bibr" target="#b10">11</ref></s><s>The reduction or absence of IFN-g signals either by anti-IFN-g treatment <ref type="bibr" target="#b11">12</ref> or using lupusprone mice lacking IFN-g <ref type="bibr" target="#b12">13</ref> or its receptor <ref type="bibr" target="#b13">14</ref> resulted in ameliorated disease, corroborating the role not only of type I but also type II interferons in patients with autoimmunity and end-organ damage.</s></p><p><s>In this study, for the first time, we demonstrate that in patients with CVIDc with immune dysregulation, the CD4 T-cell differentiation is skewed toward a T H 1 phenotype, leading to overexpression of IFN-g and accumulation of T-box transcription factor (T-bet) 1 B cells both in blood and secondary lymphoid tissues.</s><s>Our findings provide a pathophysiologic link between the association of CD21 low B-cell expansion in peripheral blood and the clinical phenotype of CVIDc.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>METHODS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Human samples</head><p><s>After ethical approval by local authorities (Freiburg 239/1999 and 121/11), written informed consent was obtained from all patients and control subjects.</s><s>Peripheral blood and tissue samples were obtained from patients with CVID seen at the immunodeficiency clinic of the Freiburg University Medical Center, Freiburg; Charit e, Berlin; or University Hospital, Frankfurt, Germany.</s><s>All lymph node and tonsil biopsy specimens were performed for medical reasons to exclude malignant lymphoma in patients with lymphadenopathy.</s><s>Tonsillar control biopsy specimens were obtained from subjects without known immunodeficiency undergoing tonsillectomy.</s><s>All patients fulfilled the criteria for CVID according to the European Society for Immunodeficiencies (www.esid.org). <ref type="bibr" target="#b14">15</ref></s><s>Next-generation sequencing was performed for 37 of 67 patients and revealed the following heterozygous mutations: nuclear factor kB subtype 1 (NFKB1) K244_D279delinsN (2 patients), NFKB1 V456* (2 patients), NFKB1 E884K, NFKB2 R853C*7, cytotoxic T lymphocyteassociated protein 4 (CTLA4) R75Q, STAT1 V266I, TNFRSF13B I87N, TNFRSF13B C104R, and TNFRSF13B S144* (1 patient each).</s><s>The following clinical data were recorded: splenomegaly (defined as a diameter of greater than 11 3 4 3 7 cm, as shown by using ultrasonography or computed tomography [CT]); generalized lymphadenopathy (lymph nodes &gt;1 cm in diameter in &gt; _2 different anatomic sites detected by means of clinical examination, ultrasonography, or CT); granulomatous disease (suggested by CT or proved by histology); autoimmune cytopenias (autoimmune hemolytic anemia or thrombocytopenia); interstitial lung disease (based on CT morphology and bronchoalveolar lavage or biopsy); and enteropathy (histology).</s><s>Patients with CVIDc were defined as having at least 1 of the following secondary complications: generalized lymphadenopathy, granulomatous disease, autoimmune cytopenia, interstitial lung disease, or enteropathy.</s><s>Patients with CVID having only splenomegaly were assigned to the CVIDio group.</s><s>Additionally, all patients were classified according to the EUROclass classification. <ref type="bibr" target="#b1">2</ref></s><s>Clinical and immunologic parameters of investigated patients are summarized in Table <ref type="table">E1</ref> in this article's Online Repository at www.jacionline.org.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Isolation of PBMCs and mononuclear cells from secondary lymphoid organs</head><p><s>PBMCs were isolated by using Ficoll density centrifugation (Pancoll; Pan-Biotech, Aidenbach, Germany).</s><s>Mononuclear cells from secondary lymphoid organs (SLOs) were isolated by means of mechanical disruption.</s><s>Tissue was minced with a scalpel, and the cell suspension was pressed through a sieve (380-mm mesh) and stored in liquid nitrogen.</s><s>Untouched memory CD4 (memCD4) T cells were isolated from PBMCs or thawed SLOs by using the memCD4 1 T Cell Isolation Kit, and untouched B cells were isolated from SLOs by using the B cell Isolation Kit II (both from Miltenyi Biotec, Bergisch Gladbach, Germany).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Flow cytometric analysis of T-and B-cell subpopulations</head><p><s>PBMCs and lymph node-derived and tonsillar mononuclear cells were labeled with the respective antibodies for detection of the indicated cellsurface molecules.</s><s>The gating strategy is shown in Fig <ref type="figure" target="#fig_0">E1, A</ref>, in this article's Online Repository at www.jacionline.org.</s><s>Peripheral blood B-cell subpopulations were analyzed, as previously described. <ref type="bibr" target="#b15">16</ref></s><s>ata were acquired on a Gallios flow cytometer (Beckman Coulter, Brea, Calif) or an LSR II flow cytometer (BD Biosciences, Franklin Lakes, NJ) and analyzed with FlowJo software (version 7.6.5 or 10; TreeStar, Ashland, Ore).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistics</head><p><s>Values were expressed as means 6 SDs.</s><s>Statistical significance was assessed for data sets with Gaussian distribution by using 1-way ANOVA followed by the Holm-Sidak test to correct for multiple testing or for data sets without Gaussian distribution by using the Kruskal-Wallis test followed by the Dunn multiple correction test, unless specified otherwise.</s><s>Statistical significance of clinical data was assessed with the Fisher exact test.</s><s>Results were analyzed with GraphPad Prism software (version 6.07; GraphPad Software, La Jolla, Calif), and P values of less than .05</s><s>were considered significant.</s></p><p><s>Additional information can be found in the Methods section in this article's Online Repository at www.jacionline.org.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>RESULTS</head><p><s>Increased percentages of CXCR3 1 CCR6 2 memCD4 T cells in patients with switched memory B 21 low CVID Based on the discovery of an altered distribution of cTFH cells (CXCR5 1 memCD4 T cells) in a subgroup of patients with genetically defined primary immunodeficiencies with hypogammaglobulinemia, we investigated memCD4 T cells in 46 patients of a well-characterized CVID cohort.</s><s>As previously reported, <ref type="bibr" target="#b16">17</ref> absolute CD4 T-cell counts affecting especially naive but also memCD4 T cells were reduced (see Fig <ref type="figure" target="#fig_1">E2, A</ref>, in this article's Online Repository at www.jacionline.org) in patients with CVIDc.</s><s>Only absolute counts of cTFH cells, derivatives of tissue TFH cells, were comparable and even relatively increased in patients with CVID when compared with those in healthy donors (HDs; see Fig <ref type="figure" target="#fig_1">E2, A</ref>).</s></p><p><s>Detailed analysis of CXCR5 1 cTFH cells (Fig <ref type="figure" target="#fig_0">1, A</ref>) and CXCR5 2 (Fig 1 <ref type="figure">, B</ref>) memCD4 T cells revealed a significant expansion of CXCR3 1 CCR6 2 T H 1 subsets in patients with CVIDc compared with patients with CVIDio and HDs, whereas the frequencies of T H 2 and T H 17 cTFH and CXCR5 2 memCD4 T cells were reduced in patients with CVIDc.</s><s>Patients with CVIDc more frequently present with an expansion of CD21 low B cells (EUROclass switched memory smB-21low), whereas the CVIDio group consists predominantly of smB-21norm patients in our cohort (P 5 .0021,</s><s>Fisher exact test).</s><s>Stratification of patients based on the EUROclass classification confirmed a significant expansion of CXCR3 1 CCR6 2 cTFH cells and CXCR5 2 memCD4 T cells in smB-21low patients compared with smB-21norm patients and HDs, whereas the frequencies of T H 2 and T H 17 cTFH cells and CXCR5 2 memCD4 T cells were reduced in smB-21low patients (Fig 1 <ref type="figure">, C and D</ref>).</s><s>This was also true for absolute counts of cTFH cells but not for CXCR5 2 memCD4 T cells (see Fig <ref type="figure" target="#fig_1">E2, C</ref>).</s><s>The altered distribution of these subsets in both T-cell compartments was stable during the investigation period (see Fig E3 in this article's Online Repository at www.jacionline.org).</s><s>In accordance with the observed T H 1 bias in smB-21low patients, mRNA levels of TBX21 (encoding for T-bet, the master regulator of T H 1 cells) in memCD4 T cells were significantly higher in smB-21 low patients than in control subjects and smB-21norm patients (Fig <ref type="figure" target="#fig_0">1, E</ref>).</s></p><p><s>This skewing toward phenotypically T H 1 memCD4 T cells was also evident in SLOs, such as lymph nodes and tonsils, of patients with CVID.</s><s>CXCR3 1 CCR6 2 T H 1 cells were increased in tonsils from patients with CVID compared with those from control subjects (51.8% 6 23.7% vs 10.64% 6 4.3%), whereas numbers of T H 2 memCD4 T cells, the main subset in tonsils, were significantly reduced (Fig 1 <ref type="figure">, F</ref>; for gating, see Fig <ref type="figure" target="#fig_0">E1, B</ref>).</s><s>This T H 1 shift in conventional memory and TFH CD4 T cells was present in all smB-21low patients but only half of the smB-21norm patients (Fig 1 <ref type="figure">, F</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Phenotypic changes are associated with increased IFN-g production in patients with CVID</head><p><s>To confirm augmented IFN-g production in memCD4 T-cell populations of patients with smB-21low CVID, we analyzed the expression of this key cytokine of T H 1 responses by using intracellular flow cytometry.</s><s>Consistent with our phenotypic findings, a significantly increased proportion of peripheral memCD4 T cells from smB-21low patients produced IFN-g both after anti-CD3/CD28 and phorbol 12-myristate 13-acetate plus ionomycin stimulation (Fig <ref type="figure" target="#fig_1">2, A</ref>).</s><s>In line with this, IFN-g production was increased in TFH cells (Fig 2 <ref type="figure">, B</ref>) and programmed cell death protein 1(PD-1)-positive non-TFH cell populations (see Fig <ref type="figure" target="#fig_3">E4, A</ref>, in this article's Online Repository at www.jacionline.org) in SLOs of patients with CVID, whereas IL-17A production was reduced (see Fig <ref type="figure" target="#fig_3">E4, B</ref>).</s><s>We also detected higher IFN-g concentrations in serum of patients with CVID, suggesting increased systemic levels, especially in smB-21low patients (Fig 2 <ref type="figure">, C</ref>).</s><s>To analyze the prevalence and type of secondary complications in patients with CVID with high IFN-g production in vitro, a cutoff was set at 40% IFN-g 1 cells after phorbol 12-myristate 13-acetate plus ionomycin stimulation according to the highest value observed in HDs in this assay.</s><s>Patients with more than 40% IFN-g 1 cells had a higher burden of autoimmune cytopenia, lymphadenopathy, interstitial lung disease, and enteropathy (Table <ref type="table" target="#tab_0">I</ref>).</s><s>The prevalence of splenomegaly or granulomatous disease did not differ between the groups.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Effect of IFN-g on GC output</head><p><s>To determine whether a shift toward T H 1 was associated with a decreased GC output, numbers of IFN-g-producing TFH cells in SLOs was compared with numbers of IgD 2 CD38 low classswitched memory B cells in SLOs.</s><s>High IFN-g production was associated with low numbers of class-switched memory B cells (Fig <ref type="figure" target="#fig_2">3, A</ref>).</s><s>To investigate a potential negative effect of IFN-g on immunoglobulin production, we stimulated isolated memCD4 T cells from tonsils of HDs and heterologous B cells from tonsils of HDs with staphylococcal enterotoxin B in the presence or absence of IFN-g or blocking antibodies to IFN-g.</s><s>Exogenous IFN-g decreased immunoglobulin secretion of IgG and IgA, whereas IgM was not affected (Fig 3 <ref type="figure">, B</ref>). Coincubation experiments with isolated B cells and CVID memCD4 T cells from tonsils of HDs did not show a difference compared with HD-derived memCD4 T cells (data not shown).</s></p><p><s>In addition to altered amounts of total IgG production, cytokines influence the differential expression of IgG subclasses.</s><s>Therefore we sequenced sorted class-switched memory B cells and plasmablasts from 3 tonsils from HDs and 3 SLOs from patients with CVID.</s><s>Consistent with previous reports, 18 g1 transcripts were the most abundant transcripts in tonsils from HDs, followed by g3, g2, and g4 (Fig <ref type="figure" target="#fig_2">3, D</ref>).</s><s>Patient 1 had a comparable IgG subclass distribution, but in patients 2 and 3, both characterized by high IFN-g production in their CD4 T-cell compartment, g2 transcripts were severely reduced.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Increased T-bet expression in lymph nodes from patients with CVID</head><p><s>Compatible with the high IFN-g production by CD4 T cells in SLOs of affected patients with CVID, we found increased numbers of T-bet-expressing cells in the GCs (Fig <ref type="figure" target="#fig_3">4, A</ref>).</s><s>There was a tendency toward high numbers of T-bet 1 cells, especially in irregularly shaped GCs compared with normal-shaped GCs within the same lymph node (Fig 4 <ref type="figure">, B</ref>).</s><s>However, the highest T-bet expression was observed in B cells located outside GCs near the sinuses (Fig 4 <ref type="figure">, C</ref>). Patients with CVID had significantly more T-bet 1 B cells in the investigated lymph nodes compared with control subjects.</s><s>The topographic distribution and high T-bet expression suggested that these cells are monocytoid B cells. <ref type="bibr" target="#b18">19</ref></s><s>The typical combination of high expression of Fc receptor-like 4 (FcRL4) and low expression of CD21 corroborated this assumption (Fig 4 <ref type="figure">, D</ref>). T-bet expression was higher in monocytoid B cells from SLOs of patients with CVID compared with those from tonsils of HDs, especially in CD21low patients (Fig 4 <ref type="figure">, E</ref>), which was compatible with a strong T H 1 environment in lymph nodes of smB-21low patients with CVID.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>CD21 low B cells are probably direct products of an IFN-g-driven immune environment</head><p><s>The group of patients with a high score of T-bet 1 monocytoid B cells was enriched for patients with high percentages of CD21 low B cells in blood (Fig <ref type="figure" target="#fig_4">5, A</ref>).</s><s>Interestingly, peripheral blood CD21 low B cells also express FcRL4, a typical marker of monocytoid B cells (Fig 5 <ref type="figure">, B</ref>), suggesting a direct relationship between both B-cell populations.</s><s>Because prominent monocytoid B-cell expansions have been seen mainly in lymph nodes of patients with T H 1-associated disorders, <ref type="bibr" target="#b19">20</ref> we hypothesized that there are signs of this IFN-g environment also present in peripheral blood-derived CD21 low B cells.</s><s>Indeed, CD21 low B cells expressed the highest T-bet levels among circulating B cells (Fig 5 <ref type="figure">, C</ref>), and gene expression profiling of CD21 low B cells revealed an interferon signature (Fig 5 <ref type="figure">, D</ref>), implying a direct link between the IFN-g-associated immune dysregulation and expansion of this unusual B-cell population.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>DISCUSSION</head><p><s>Supporting previous findings in defined monogenetic forms of primary immunodeficiency, <ref type="bibr" target="#b3">4</ref> we observed a T H 1-skewed cTFH cell differentiation in patients with CVIDc.</s><s>Analysis of SLOs revealed that the predominance of the T H 1 phenotype is not limited to peripheral blood but also manifests directly in TFH cells within GCs.</s><s>We corroborated this phenotypic finding by demonstrating an increased percentage of IFN-g-producing memory T cells in blood and SLOs and increased IFN-g serum levels.</s><s>There are  conflicting results in regard to IFN-g in patients with CVID. <ref type="bibr" target="#b20">21</ref></s><s>tudies taking into account the heterogeneity of patients with CVID identified a subgroup of patients with low naive CD4 Tcell numbers and increased IFN-g production. <ref type="bibr" target="#b21">22</ref></s><s>Also, in the context of enteropathy, mucosa-infiltrating T cells in patients with CVID are mainly of the T H 1 subset, whereas T H 17 cell numbers are reduced compared with those in patients with Crohn disease. <ref type="bibr" target="#b22">23</ref></s><s>cently, Cols et al <ref type="bibr" target="#b23">24</ref> identified an association of increased IFN-g levels with the manifestation of secondary complications in patients with CVID. <ref type="bibr" target="#b23">24</ref></s><s>Also, in our cohort increased serum IFN-g levels were associated with the clinical presentation of CVIDc.</s><s>Cols et al correlated the IFN-g signature to an expansion of IFN-g-producing innate lymphoid cells.</s><s>In our cohort we find a T H 1-skewed memCD4 T-cell differentiation associated with this clinical phenotype.</s><s>This was not only associated with the manifestation of enteropathy but also autoimmune cytopenia, interstitial lung disease, and lymphadenopathy.</s><s>Given the abundance of T cells compared with innate lymphoid cells as a source of IFN-g, we assume that T cells contribute substantially to the interferon signature observed in patients with CVIDc.</s></p><p><s>The underlying mechanism for the skewed differentiation of memCD4 T cells toward a T H 1 phenotype in patients with CVIDc remains to be determined.</s><s>The TFH phenotype of all defined monogenetic defects with CVID-like disorders could not be distinguished from that of the other patients with CVID in our cohort.</s><s>We could not detect a more severe humoral immunodeficiency and therefore increased general infection rate in patients with CVIDc versus those with CVIDio.</s><s>However, expansions of T H 1 cTFH cells are reported in the context of recent viral antigen exposure.</s><s>The expansion of antigen-specific inducible costimulator (ICOS)-expressing CXCR3 1 cTFH cells has been observed after influenza vaccination, <ref type="bibr" target="#b24">25</ref> as well as in the acute phase of hepatitis C virus (HCV) and EBV infection. <ref type="bibr" target="#b25">26</ref></s><s>In contrast to influenzavaccinated subjects and patients with HCV in whom the numbers of (antigen-specific) ICOS 1 CXCR3 1 cTFH cells return to baseline levels within 6 weeks, we see a stable increase in numbers of T H 1 cTFH cells in patients with CVIDc over months.</s><s>A similar polarization toward T H 1 affecting the whole memCD4 T-cell compartment <ref type="bibr" target="#b26">27</ref> and specifically the cTFH compartment 28 is reported for HIV-infected patients during the chronic phase.</s><s>Moreover, animal models of simian immunodeficiency virus infection in rhesus macaques demonstrated that chronic simian immunodeficiency virus infection promotes expansion of T H 1-biased GC TFH cells, <ref type="bibr" target="#b28">29</ref> which was similar to our observations in SLOs of patients with CVID.</s><s>Cubas et al <ref type="bibr" target="#b27">28</ref> suggested that chronic immune activation drives memory TFH cell polarization toward a T H 1-like phenotype in chronically infected patients with HIV.</s><s>In our cohort we observed intermittent reactivation of cytomegalovirus or EBV in 9 of 55 patients, whereas in the majority of our patients, a chronic viral infection still remained elusive.</s></p><p><s>The strongest T H 1 shift of TFH cells was observed in patients with an expansion of circulating CD21 low B cells.</s><s>Here we show that these cells express the highest levels of T-bet among peripheral blood lymphocytes and carry an interferon signature.</s><s>This suggests that CVID CD21 low B cells themselves are probably driven by a T H 1 environment and therefore might serve as a marker for T H 1-associated immune dysregulation.</s><s>This hypothesis is supported by IFN-g-driven induction of age-associated B cells, a murine analog of human CD21 low B cells. <ref type="bibr" target="#b29">30</ref></s><s>Studies in mice suggest that this unique T-bet 1 B-cell population is induced by synergistic signaling through the B-cell receptor, Toll-like receptor 7, and the IFN-g receptor.</s><s>They arise during viral infection and are essential for efficient viral clearance <ref type="bibr" target="#b29">30,</ref><ref type="bibr" target="#b30">31</ref> but also participate in the pathogenesis of autoimmune reactions in lupus-prone mice. <ref type="bibr" target="#b31">32,</ref><ref type="bibr" target="#b32">33</ref></s><s>Interestingly, the same association has been observed for human CD21 low B cells, which are found not only in peripheral blood of patients with CVID <ref type="bibr" target="#b33">34</ref> but also in patients with autoimmune diseases, such as rheumatoid arthritis <ref type="bibr" target="#b34">35</ref> and systemic lupus erythematosus, <ref type="bibr" target="#b35">36,</ref><ref type="bibr" target="#b36">37</ref> as well as in patients with chronic infections, such as HIV, <ref type="bibr" target="#b37">38</ref> HCV, <ref type="bibr" target="#b38">39</ref> and malaria. <ref type="bibr" target="#b39">40</ref></s><s><ref type="bibr" target="#b37">[38]</ref><ref type="bibr" target="#b38">[39]</ref><ref type="bibr" target="#b39">[40]</ref><ref type="bibr" target="#b40">[41]</ref><ref type="bibr" target="#b41">[42]</ref><ref type="bibr" target="#b42">[43]</ref><ref type="bibr" target="#b43">[44]</ref><ref type="bibr" target="#b44">[45]</ref><ref type="bibr" target="#b45">[46]</ref><ref type="bibr" target="#b46">[47]</ref><ref type="bibr" target="#b47">[48]</ref><ref type="bibr" target="#b48">[49]</ref><ref type="bibr" target="#b49">[50]</ref><ref type="bibr" target="#b50">[51]</ref> Although originally we had not found the equivalent of these cells in lymph nodes of patients with CVID, <ref type="bibr" target="#b33">34</ref> an optimized marker combination and T-bet expression demonstrated that sinusoidal B cells are the closest related population, which probably overlap with FcRL4 1 tissue memory-like B cells <ref type="bibr" target="#b51">52</ref> and morphologically described monocytoid B cells. <ref type="bibr" target="#b52">53</ref></s><s>The pathologic increase in numbers of T-bet 1 B cells in the lymph nodes of patients with CVID resembles findings in the context of T H 1 immune responses against intracellular pathogens, such as HIV and toxoplasma <ref type="bibr" target="#b19">20</ref> and in the placentas of malaria-infected women. <ref type="bibr" target="#b40">41</ref></s><s>Interestingly, for several of these diseases, the presence of irregularly shaped GCs has been described (Table <ref type="table" target="#tab_1">II</ref>), proposing a potential association between the T H 1 milieu and GC morphology, which needs further explanation.</s><s>Here, for the first time, we were able to describe both circulating B and memCD4 T cells and SLO-derived B and TFH cells of the same patient in the setting of CVID, linking alterations of both compartments.</s></p><p><s>We found a negative correlation between the amount of IFNg-producing TFH cells in SLOs and the presence of classswitched memory B cells in patients with CVID, suggesting a negative influence of T H 1-polarized TFHs on B-cell memory formation.</s><s>There is evidence from other diseases, such as HIV <ref type="bibr" target="#b53">54</ref> and malaria, <ref type="bibr" target="#b41">42</ref> that CXCR3 1 cTFH cells (consisting of cTH1 and cTH1/17 cells) are less efficient B-cell helpers compared with CXCR3 2 cTFH cells (consisting of cTH2 and cTH17 cells), resulting in suboptimal specific antibody responses.</s><s>In line with this idea, our in vitro experiments corroborated that exogenous IFN-g reduces IgG and IgA production in B/T-cell cocultures. <ref type="bibr" target="#b27">28,</ref><ref type="bibr" target="#b54">55</ref></s><s>The cytokine milieu impacts class-switching. <ref type="bibr" target="#b55">56</ref></s><s>This is well established in murine models, where IFN-g induces g2 transcripts and IL-4 induces g1 and ε transcripts. <ref type="bibr" target="#b56">57</ref></s><s>Similarly, IL-4 induces IgG 4 and IgE secretion in human B cells, <ref type="bibr" target="#b57">58</ref> but to our knowledge, no specific human IgG subclass has been linked with IFN-g.</s><s>Analysis of antibodies directed against viral proteins revealed an IgG 1 /IgG 3 predominance and an IgG 2 predominance against polysaccharides. <ref type="bibr" target="#b58">59</ref></s><s>In this study we observed a selective reduction of g2 transcripts in class-switched memory B cells and plasmablasts of patients with T H 1-biased TFH cells, whereas the patient with CVID with a normally distributed TFH compartment expressed all g-transcripts at levels comparable with those in control subjects.</s><s>A similar skewing of IgG subclasses with reduced IgG 2 levels is common in HIV-infected patients, <ref type="bibr" target="#b59">60</ref> whose memCD4 T-cell compartment is also T H 1 biased, as discussed above. <ref type="bibr" target="#b26">27,</ref><ref type="bibr" target="#b27">28</ref></s><s>It is remarkable in this context that we observed preexisting IgG 2 /IgG 4 subclass deficiencies in 4 patients with full CVID with a T H 1-like environment.</s><s>Further studies will need to verify the hypothesis that a T H 1 bias in GCs is the underlying cause of IgG 2 /IgG 4 deficiency.</s><s>In addition, it will be interesting to test whether a constellation of IgG 2 /IgG 4 deficiency, an expansion of CD21 low B cells and T H 1 bias might be able to identify patients with CVID who are prone to manifestations of immune dysregulation and should be monitored more closely in this respect.</s></p><p><s>In summary, for the first time, we demonstrated that patients with CVIDc harbor a T H 1-biased CD4 compartment both in blood and in secondary lymphoid tissues.</s><s>This mirrors recent reports that linked CD4 T cells with a T H 1 phenotype to the development of autoimmune manifestations in patients with diabetes mellitus <ref type="bibr" target="#b60">61</ref> and rheumatoid arthritis. <ref type="bibr" target="#b61">62</ref></s><s>Our results provide a pathophysiologic link between the abundance of IFNg-producing TFH cells, the expansion of CD21 low B-cell numbers in peripheral blood, and the clinical phenotype of CVIDc.</s><s>We suggest that CD21 low B-cell expansion might serve as a biological marker for a T H 1-associated immune dysregulation in patients with CVIDc and that IgG 2 /IgG 4 subclass deficiency might be linked to this immune dysregulation.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>FIG 1 .</head><label>1</label><figDesc><div><p><s>FIG 1.</s><s>The CD4 T-cell compartment is skewed toward T H 1 in patients with CVIDc.</s><s>A-D, cTFH1, cTFH1/17, cTFH2, and cTFH17 (Fig 1, A and C) and T H 1, T H 1/17, T H 2, and T H 17 (Fig 1, B and D) cell subsets in PBMCs of HDs and patients with CVID.</s><s>E, Expression of TBX21 in CD4 memory T cells.</s><s>F, T H 1, T H 1/17, T H 2, and T H 17 subsets in tonsils from HDs and SLOs from patients with CVID.</s><s>*P &lt; .05,</s><s>**P &lt; .01,</s><s>***P &lt; .005,</s><s>and ****P &lt; .001.</s></p></div></figDesc><graphic coords="4,54.71,65.59,479.48,602.59" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>FIG 2 .</head><label>2</label><figDesc><div><p><s>FIG 2. Increased IFN-g production by memCD4 T cells in patients with CVID.</s><s>A, Intracellular IFN-g production on stimulation with plate-bound anti-CD3 and soluble anti-CD28 or phorbol 12-myristate 13-acetate (PMA) and ionomycin (Iono) in peripheral blood memCD4 T cells.</s><s>B, Intracellular IFN-g production on stimulation with PMA plus ionomycin in TFH cells of tonsils from patients with HD and SLOs from patients with CVID.</s><s>C, IFN-g concentration in serum.</s><s>*P &lt; .05,</s><s>**P &lt; .01,</s><s>and ****P &lt; .001.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>FIG 3 .</head><label>3</label><figDesc><div><p><s>FIG 3. Effect of IFN-g on GC-derived B cell populations.</s><s>A, Correlation of IFN-g production on stimulation with phorbol 12-myristate 13-acetate (PMA) plus ionomycin in TFH cells with class-switched (cs) memory B cells in SLOs.</s><s>B, IgG, IgA, and IgM production of allogenic T-cell/B-cell cocultures of tonsils in the presence of IFN-g, IFN-g blockade (aIFN-g), or isotype control (iso) after 5 days.</s><s>C, Distribution of IgG subclass transcripts in SLOs.</s><s>*P &lt; .05 and **P &lt; .01. ns, Not significant.</s></p></div></figDesc><graphic coords="6,90.54,65.59,407.72,493.17" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>FIG 4 .</head><label>4</label><figDesc><div><p><s>FIG 4. Increased T-bet expression in lymph nodes from patients with CVID and CD21 low B cells.</s><s>A, Lymph node sections from control subjects and patients with CCID were stained for CD20 (red) and T-bet (brown).</s><s>Lymph nodes from patients with CVID contained increased numbers of T-bet 1 nuclei in GCs, especially in irregularly shaped GCs.</s><s>High-resolution versions of the slides for use with the Virtual Microscope are available as eSlide: VM04082, eSlide: VM04083, eSlide: VM04084 and eSlide: VM04085.</s><s>B, Accumulation of Tbet 1 cells in irregularly shaped GCs.</s><s>C, Accumulation of monocytoid T-bet 1 B cells in lymph nodes from patients with CVID.</s><s>High-resolution versions of the slides for use with the Virtual Microscope are available as eSlide: VM04086, eSlide: VM04087, eSlide: VM04088 and eSlide: VM04089.</s><s>D, FcRL4 and CD21 expression on B cells in tonsils from patients with HDs and a patient with CVID.</s><s>E, FcRL4 1 CD21 low monocytoid B cells in SLOs from patients with CVID express higher T-bet levels compared with tonsils from HDs. *P &lt; .05.</s></p></div></figDesc><graphic coords="7,86.74,65.59,407.72,476.33" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>FIG 5 .</head><label>5</label><figDesc><div><p><s>FIG 5. Interferon signature in CD21 low B cells.</s><s>A, Correlation of monocytoid T-bet 1 B cells in SLOs with CD21 low B cells in blood.</s><s>B, Increased FcRL4 expression in CD21 low B cells.</s><s>C, Increased T-bet expression in CD21 low B cells in blood.</s><s>D, Interferon-responsive genes in CD21 low B cells (4 patients with CVID) and naive B cells (3 patients with CVID and 4 HDs).</s><s>Columns represent individual samples.</s><s>Color changes indicate expression levels relative to the average of the sample population according to the color bar.</s><s>Validation is indicated by an arrowhead.</s><s>**P &lt; .01 and ****P &lt; .001.</s></p></div></figDesc><graphic coords="8,105.56,65.59,377.74,414.43" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>TABLE I .</head><label>I</label><figDesc><div><p><s>Association of increased percentage of IFN-g-producing memCD4 T cells with complications in patients with CVID</s></p></div></figDesc><table><row><cell></cell><cell cols="2">Patients with:</cell><cell></cell></row><row><cell></cell><cell>&gt;40% IFN-g</cell><cell>&lt;40% IFN-g</cell><cell></cell></row><row><cell></cell><cell>(% of memCD4</cell><cell>(% of memCD4</cell><cell></cell></row><row><cell></cell><cell>T cells)</cell><cell>T cells)</cell><cell>P value</cell></row><row><cell>Splenomegaly</cell><cell>89%</cell><cell>86%</cell><cell>NS</cell></row><row><cell>Lymphadenopathy</cell><cell>89%</cell><cell>14%</cell><cell>&lt;.0001</cell></row><row><cell>Autoimmune cytopenia</cell><cell>44%</cell><cell>14%</cell><cell>&lt;.0001</cell></row><row><cell>Granuloma</cell><cell>67%</cell><cell>57%</cell><cell>NS</cell></row><row><cell>Interstitial lung disease</cell><cell>89%</cell><cell>43%</cell><cell>&lt;.0001</cell></row><row><cell>Enteropathy</cell><cell>50%</cell><cell>20%</cell><cell>&lt;.0001</cell></row></table><note><p><s>NS, Not significant.</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>TABLE II .</head><label>II</label><figDesc><div><p><s>Disease conditions with T H 1-polarized CD4 T-cell compartment and CD21 low B cells</s></p></div></figDesc><table><row><cell></cell><cell>CVID smB-21low</cell><cell>HIV</cell><cell>Malaria</cell><cell>Toxoplasma</cell><cell>HCV</cell></row><row><cell>Skewing toward T H 1 in CD4 T cells</cell><cell>Yes (this publication)</cell><cell>Yes 27,28</cell><cell>Yes 42,43</cell><cell>Yes 44</cell><cell>Yes 26,45</cell></row><row><cell>Circulating CD21 low B cells</cell><cell>Yes 46</cell><cell>Yes 38</cell><cell>Yes 40</cell><cell>Not known</cell><cell>Yes 39</cell></row><row><cell>T-bet expression in B cells</cell><cell>Yes (this publication)</cell><cell>Yes 20</cell><cell>Yes 41</cell><cell>Yes 20</cell><cell>Not known</cell></row><row><cell>Impaired B-cell function</cell><cell>Yes 46</cell><cell>Yes 38</cell><cell>Yes 47</cell><cell>Not known</cell><cell>Not known</cell></row><row><cell>Irregularly shaped GCs</cell><cell>Yes 48</cell><cell>Yes 49</cell><cell>Yes 50</cell><cell>Yes 51</cell><cell>Not known</cell></row></table></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">J ALLERGY CLIN IMMUNOL VOLUME 141, NUMBER 2</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">J ALLERGY CLIN IMMUNOLFEBRUARY 2018</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>We thank Hermann Eibel, Hanspeter Pircher and Hans-Hartmut Peter for discussion and critical reading of the manuscript.</s><s>We thank the physicians who cared for the patients, Helene Kraus, and study nurses Marion Klima and Monika Erler for their support, as well as all our patients.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Clinical implications: Patients with CVID with secondary complications and an expansion of CD21 low B cells need to be evaluated for causes of a T H 1-associated pathophysiology.</s><s>This rationale might offer new targeted therapeutic avenues.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">The many faces of the clinical picture of common variable immune deficiency</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">S</forename><surname>Resnick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Cunningham-Rundles</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Opin Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="595" to="601" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">The EUROclass trial: defining subgroups in common variable immunodeficiency</title>
		<author>
			<persName><forename type="first">C</forename><surname>Wehr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kivioja</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Schmitt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Ferry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Witte</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Eren</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">111</biblScope>
			<biblScope unit="page" from="77" to="85" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Common variable immunodeficiency disorders: division into distinct clinical phenotypes</title>
		<author>
			<persName><forename type="first">H</forename><surname>Chapel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Lucas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bjorkander</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Webster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Grimbacher</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">112</biblScope>
			<biblScope unit="page" from="277" to="286" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Monogenic mutations differentially affect the quantity and quality of T follicular helper cells in patients with human primary immunodeficiencies</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Wong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Rao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">T</forename><surname>Avery</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Torpy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Hambridge</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">136</biblScope>
			<biblScope unit="page" from="993" to="1006" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>e1</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">CXCR5 expressing human central memory CD4 T cells and their relevance for humoral immune responses</title>
		<author>
			<persName><forename type="first">N</forename><surname>Chevalier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Jarrossay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Ho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">T</forename><surname>Avery</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Yu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">186</biblScope>
			<biblScope unit="page" from="5556" to="5568" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Human blood CXCR5(1)CD4(1) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion</title>
		<author>
			<persName><forename type="first">R</forename><surname>Morita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Schmitt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Bentebibel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Ranganathan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Bourdery</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Zurawski</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunity</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="108" to="121" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Interferon signature in the blood in inflammatory common variable immune deficiency</title>
		<author>
			<persName><forename type="first">J</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Munagala</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Blankenship</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Maffucci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Chaussabel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">e74893</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">C</forename><surname>Baechler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">M</forename><surname>Batliwalla</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Karypis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Gaffney</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">A</forename><surname>Ortmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">J</forename><surname>Espe</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci U S A</title>
		<imprint>
			<biblScope unit="volume">100</biblScope>
			<biblScope unit="page" from="2610" to="2615" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Systemic lupus erythematosus: presence in human serum of an unusual acid-labile leukocyte interferon</title>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">T</forename><surname>Preble</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Black</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Friedman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Klippel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Vilcek</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">216</biblScope>
			<biblScope unit="page" from="429" to="431" />
			<date type="published" when="1982">1982</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Serum levels of interferons in patients with systemic lupus erythematosus</title>
		<author>
			<persName><forename type="first">T</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Kanayama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Negoro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Okamura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Takeda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Inoue</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Exp Immunol</title>
		<imprint>
			<biblScope unit="volume">70</biblScope>
			<biblScope unit="page" from="562" to="569" />
			<date type="published" when="1987">1987</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Interferongamma excess leads to pathogenic accumulation of follicular helper T cells and germinal centers</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Silva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Martin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Pratama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Hu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">P</forename><surname>Chang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunity</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="880" to="892" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Experimental therapy of systemic lupus erythematosus: the treatment of NZB/W mice with mouse soluble interferon-gamma receptor inhibits the onset of glomerulonephritis</title>
		<author>
			<persName><forename type="first">L</forename><surname>Ozmen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Roman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Fountoulakis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Schmid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Ryffel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Garotta</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Immunol</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="6" to="12" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Roles of interferon-gamma and interleukin-4 in murine lupus</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Peng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Moslehi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Craft</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">99</biblScope>
			<biblScope unit="page" from="1936" to="1946" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">IFN-gamma receptor deletion prevents autoantibody production and glomerulonephritis in lupus-prone (NZB x NZW)F1 mice</title>
		<author>
			<persName><forename type="first">C</forename><surname>Haas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Ryffel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Le</forename><surname>Hir</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">160</biblScope>
			<biblScope unit="page" from="3713" to="3718" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">International Consensus Document (ICON): common variable immunodeficiency disorders</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">A</forename><surname>Bonilla</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Barlan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Chapel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">T</forename><surname>Costa-Carvalho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Cunningham-Rundles</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">T</forename><surname>De La Morena</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol Pract</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="38" to="59" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Secondary antibody deficiency in glucocorticoid therapy clearly differs from primary antibody deficiency</title>
		<author>
			<persName><forename type="first">C</forename><surname>Wirsum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Glaser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Gutenberger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Keller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Unger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Voll</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="406" to="412" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">T cell phenotypes in patients with common variable immunodeficiency disorders: associations with clinical phenotypes in comparison with other groups with recurrent infections</title>
		<author>
			<persName><forename type="first">Eal</forename><surname>Bateman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Ayers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Sadler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Lucas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Roberts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Woods</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Exp Immunol</title>
		<imprint>
			<biblScope unit="volume">170</biblScope>
			<biblScope unit="page" from="202" to="211" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">IgG subclass expression by human B lymphocytes and plasma cells: B lymphocytes precommitted to IgG subclass can be preferentially induced by polyclonal mitogens with T cell help</title>
		<author>
			<persName><forename type="first">M</forename><surname>Mayumi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kuritani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kubagawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Cooper</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">130</biblScope>
			<biblScope unit="page" from="671" to="677" />
			<date type="published" when="1983">1983</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">T-bet-positive and IRTA1-positive monocytoid B cells differ from marginal zone B cells and epithelial-associated B cells in their antigen profile and topographical distribution</title>
		<author>
			<persName><forename type="first">K</forename><surname>Johrens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Shimizu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Anagnostopoulos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Schiffmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Tiacci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Falini</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Haematologica</title>
		<imprint>
			<biblScope unit="volume">90</biblScope>
			<biblScope unit="page" from="1070" to="1077" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Different T-bet expression patterns characterize particular reactive lymphoid tissue lesions</title>
		<author>
			<persName><forename type="first">K</forename><surname>Johrens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Anagnostopoulos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Durkop</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Stein</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Histopathology</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="page" from="343" to="352" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Cytokines in common variable immunodeficiency as signs of immune dysregulation and potential therapeutic targets-a review of the current knowledge</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">N</forename><surname>Varzaneh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Keller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Unger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Aghamohammadi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Warnatz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Rezaei</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="524" to="543" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Unravelling the complexity of T cell abnormalities in common variable immunodeficiency</title>
		<author>
			<persName><forename type="first">A</forename><surname>Giovannetti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Pierdominici</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Mazzetta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Marziali</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Renzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Mileo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">178</biblScope>
			<biblScope unit="page" from="3932" to="3943" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Excess IL-12 but not IL-23 accompanies the inflammatory bowel disease associated with common variable immunodeficiency</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Mannon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">J</forename><surname>Fuss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Dill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Friend</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Groden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Hornung</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gastroenterology</title>
		<imprint>
			<biblScope unit="volume">131</biblScope>
			<biblScope unit="page" from="748" to="756" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Expansion of inflammatory innate lymphoid cells in patients with common variable immune deficiency</title>
		<author>
			<persName><forename type="first">M</forename><surname>Cols</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Rahman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Maglione</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Garcia-Carmona</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Simchoni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">B</forename><surname>Ko</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">137</biblScope>
			<biblScope unit="page" from="e1" to="6" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Induction of ICOS1CXCR31CXCR51 TH cells correlates with antibody responses to influenza vaccination</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Bentebibel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Lopez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Obermoser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Schmitt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Mueller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Harrod</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Sci Transl Med</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="176" to="208" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Virus-specific CD41 T cells have functional and phenotypic characteristics of follicular T-helper cells in patients with acute and chronic HCV infections</title>
		<author>
			<persName><forename type="first">B</forename><surname>Raziorrouh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Sacher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">G</forename><surname>Tawar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Emmerich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Neumann-Haefelin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">F</forename><surname>Baumert</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gastroenterology</title>
		<imprint>
			<biblScope unit="volume">150</biblScope>
			<biblScope unit="page" from="696" to="706" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note>e3</note>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Peripheral blood CCR41CCR61 and CXCR31CCR61CD41 T cells are highly permissive to HIV-1 infection</title>
		<author>
			<persName><forename type="first">A</forename><surname>Gosselin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Monteiro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Chomont</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Diaz-Griffero</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Said</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Fonseca</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">184</biblScope>
			<biblScope unit="page" from="1604" to="1616" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Reversible reprogramming of circulating memory T follicular helper cell function during chronic HIV infection</title>
		<author>
			<persName><forename type="first">R</forename><surname>Cubas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Van Grevenynghe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Wills</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Kardava</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">H</forename><surname>Santich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Buckner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">195</biblScope>
			<biblScope unit="page" from="5625" to="5636" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Induction of Th1-biased T follicular helper (Tfh) cells in lymphoid tissues during chronic simian immunodeficiency virus infection defines functionally distinct germinal center Tfh cells</title>
		<author>
			<persName><forename type="first">V</forename><surname>Velu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">H</forename><surname>Mylvaganam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Gangadhara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Hong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Iyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Gumber</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">197</biblScope>
			<biblScope unit="page" from="1832" to="1842" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">T-box transcription factor T-bet, a key player in a unique type of B-cell activation essential for effective viral clearance</title>
		<author>
			<persName><forename type="first">K</forename><surname>Rubtsova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">V</forename><surname>Rubtsov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">F</forename><surname>Van Dyk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Kappler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Marrack</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci U S A</title>
		<imprint>
			<biblScope unit="volume">110</biblScope>
			<biblScope unit="page" from="E3216" to="3224" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Cutting edge: B cell-intrinsic T-bet expression is required to control chronic viral infection</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">E</forename><surname>Barnett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Staupe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Odorizzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Palko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">T</forename><surname>Tomov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Mahan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">197</biblScope>
			<biblScope unit="page" from="1017" to="1022" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Toll-like receptor 7 (TLR7)-driven accumulation of a novel CD11c(1) B-cell population is important for the development of autoimmunity</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">V</forename><surname>Rubtsov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Rubtsova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Fischer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">T</forename><surname>Meehan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">Z</forename><surname>Gillis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Kappler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">118</biblScope>
			<biblScope unit="page" from="1305" to="1315" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Age-associated B cells: a T-betdependent effector with roles in protective and pathogenic immunity</title>
		<author>
			<persName><forename type="first">K</forename><surname>Rubtsova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">V</forename><surname>Rubtsov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Cancro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Marrack</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">195</biblScope>
			<biblScope unit="page" from="1933" to="1937" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Circulating CD21low B cells in common variable immunodeficiency resemble tissue homing, innate-like B cells</title>
		<author>
			<persName><forename type="first">M</forename><surname>Rakhmanov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Keller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Gutenberger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Foerster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hoenig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Driessen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci U S A</title>
		<imprint>
			<biblScope unit="volume">106</biblScope>
			<biblScope unit="page" from="13451" to="13456" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Complement receptor 2/CD21-human naive B cells contain mostly autoreactive unresponsive clones</title>
		<author>
			<persName><forename type="first">I</forename><surname>Isnardi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">S</forename><surname>Ng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Menard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Meyers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Saadoun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Srdanovic</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">115</biblScope>
			<biblScope unit="page" from="5026" to="5036" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">A new CD21low B cell population in the peripheral blood of patients with SLE</title>
		<author>
			<persName><forename type="first">C</forename><surname>Wehr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Eibel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Masilamani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Illges</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Schlesier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">H</forename><surname>Peter</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">113</biblScope>
			<biblScope unit="page" from="161" to="171" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Diversity, cellular origin and autoreactivity of antibody-secreting cell population expansions in acute systemic lupus erythematosus</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Tipton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">F</forename><surname>Fucile</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Darce</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Chida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Ichikawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Gregoretti</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Immunol</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="755" to="765" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals</title>
		<author>
			<persName><forename type="first">S</forename><surname>Moir</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Malaspina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Dipoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O'</forename><surname>Shea</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Exp Med</title>
		<imprint>
			<biblScope unit="volume">205</biblScope>
			<biblScope unit="page" from="1797" to="1805" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Expansion of functionally anergic CD21-/low marginal zone-like B cell clones in hepatitis C virus infection-related autoimmunity</title>
		<author>
			<persName><forename type="first">B</forename><surname>Terrier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Joly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Vazquez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Benech</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Rosenzwajg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Carpentier</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">187</biblScope>
			<biblScope unit="page" from="6550" to="6563" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Atypical memory B cells are greatly expanded in individuals living in a malaria-endemic area</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">E</forename><surname>Weiss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">D</forename><surname>Crompton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Walsh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Moir</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Traore</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">183</biblScope>
			<biblScope unit="page" from="2176" to="2182" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Genomewide expression analysis of placental malaria reveals features of lymphoid neogenesis during chronic infection</title>
		<author>
			<persName><forename type="first">A</forename><surname>Muehlenbachs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Fried</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Lachowitzer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">K</forename><surname>Mutabingwa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">E</forename><surname>Duffy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">179</biblScope>
			<biblScope unit="page" from="557" to="565" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Circulating Th1-cell-type Tfh cells that exhibit impaired B cell help are preferentially activated during acute malaria in children</title>
		<author>
			<persName><forename type="first">N</forename><surname>Obeng-Adjei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Portugal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Tran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">B</forename><surname>Yazew</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Skinner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Li</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Rep</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="425" to="439" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Severe malaria infections impair germinal center responses by inhibiting T follicular helper cell differentiation</title>
		<author>
			<persName><forename type="first">V</forename><surname>Ryg-Cornejo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Ioannidis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">Y</forename><surname>Chiu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Tellier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Hill</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Rep</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="68" to="81" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Presence of gamma interferon in human acute and congenital toxoplasmosis</title>
		<author>
			<persName><forename type="first">J</forename><surname>Raymond</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Poissonnier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">H</forename><surname>Thulliez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Forestier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Daffos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Lebon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Microbiol</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="1434" to="1437" />
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Predominance of type 1 (Th1) cytokine production in the liver of patients with HCV-associated mixed cryoglobulinemia vasculitis</title>
		<author>
			<persName><forename type="first">D</forename><surname>Saadoun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Boyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Trebeden-Negre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Limal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Bon-Durand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Andreu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Hepatol</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="1031" to="1037" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Severe deficiency of switched memory B cells (CD27(1)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease</title>
		<author>
			<persName><forename type="first">K</forename><surname>Warnatz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Denz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Drager</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Braun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Groth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Wolff-Vorbeck</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">99</biblScope>
			<biblScope unit="page" from="1544" to="1551" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<monogr>
		<title level="m" type="main">Malaria-associated atypical memory B cells exhibit markedly reduced B cell receptor signaling and effector function</title>
		<author>
			<persName><forename type="first">S</forename><surname>Portugal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Tipton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Sohn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Kone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Li</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2015">2015</date>
			<biblScope unit="volume">4</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Illdefined germinal centers and severely reduced plasma cells are histological hallmarks of lymphadenopathy in patients with common variable immunodeficiency</title>
		<author>
			<persName><forename type="first">S</forename><surname>Unger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Seidl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Schmitt-Graeff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bohm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Schrenk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Wehr</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="615" to="626" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Progressive histopathologic abnormalities in the persistent generalized lymphadenopathy syndrome</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">R</forename><surname>Turner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Levine</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">S</forename><surname>Gill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Parker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">R</forename><surname>Meyer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Surg Pathol</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="625" to="632" />
			<date type="published" when="1987">1987</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Germinal center architecture disturbance during Plasmodium berghei ANKA infection in CBA mice</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Carvalho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Ferreira-Da-Cruz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">T</forename><surname>Daniel-Ribeiro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Pelajo-Machado</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">L</forename><surname>Lenzi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Malaria J</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page">59</biblScope>
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Infectious mononucleosis lymphoadenitis showing histologic findings indistinguishable from toxoplasma lymphadenitis. A report of three cases</title>
		<author>
			<persName><forename type="first">M</forename><surname>Kojima</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kashimura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Itoh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Noro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Matsuda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Tsukamoto</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pathol Res Pract</title>
		<imprint>
			<biblScope unit="volume">206</biblScope>
			<biblScope unit="page" from="361" to="364" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Discriminating gene expression profiles of memory B cell subpopulations</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Ehrhardt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Hijikata</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kitamura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Ohara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Cooper</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Exp Med</title>
		<imprint>
			<biblScope unit="volume">205</biblScope>
			<biblScope unit="page" from="1807" to="1817" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Unique phenotypic profile of monocytoid B cells: differences in comparison with the phenotypic profile observed in marginal zone B cells and so-called monocytoid B cell lymphoma</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">I</forename><surname>Camacho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Garcia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Sanchez-Verde</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">I</forename><surname>Saez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sanchez-Beato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mollejo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Pathol</title>
		<imprint>
			<biblScope unit="volume">158</biblScope>
			<biblScope unit="page" from="1363" to="1369" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">Human circulating PD-11CXCR3-CXCR51 memory Tfh cells are highly functional and correlate with broadly neutralizing HIV antibody responses</title>
		<author>
			<persName><forename type="first">M</forename><surname>Locci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Havenar-Daughton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Landais</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Kroenke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Arlehamn</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunity</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="758" to="769" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">Human CD571 germinal center-T cells are the major helpers for GC-B cells and induce class switch recombination</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">W</forename><surname>Lim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">G</forename><surname>Kang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Hillsamer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Kim</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC Immunol</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page">3</biblScope>
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">Mechanism and regulation of class switch recombination</title>
		<author>
			<persName><forename type="first">J</forename><surname>Stavnezer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Guikema</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Schrader</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Annu Rev Immunol</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="261" to="292" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">Induction of germ-line immunoglobulin heavy chain transcripts by mitogens and interleukins prior to switch recombination</title>
		<author>
			<persName><forename type="first">E</forename><surname>Severinson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Fernandez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Stavnezer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Immunol</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="1079" to="1084" />
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">Interleukin 4 induces synthesis of IgE and IgG4 in human B cells</title>
		<author>
			<persName><forename type="first">M</forename><surname>Lundgren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Persson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Larsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Magnusson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">I</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Hammarstrom</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Immunol</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="1311" to="1315" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main">Serum immunoglobulin G subclass dysbalances in the lymphadenopathy syndrome and acquired immune deficiency syndrome</title>
		<author>
			<persName><forename type="first">P</forename><surname>Aucouturier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Couderc</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Gouet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Danon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Gombert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Matheron</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Exp Immunol</title>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="page" from="234" to="240" />
			<date type="published" when="1986">1986</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main">Immunoglobulin G subclass levels and antibody responses to the 2009 influenza A (H1N1) monovalent vaccine among human immunodeficiency virus (HIV)-infected and HIV-uninfected adults</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">F</forename><surname>Crum-Cianflone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Collins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Defang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Iverson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">E</forename><surname>Eberly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Duplessis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Exp Immunol</title>
		<imprint>
			<biblScope unit="volume">168</biblScope>
			<biblScope unit="page" from="135" to="141" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main">A divergent population of autoantigen-responsive CD41 T cells in infants prior to beta cell autoimmunity</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K</forename><surname>Heninger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Eugster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Kuehn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Buettner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kuhn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lindner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Sci Transl Med</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">378</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main">Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Rao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Gurish</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Marshall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Slowikowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">Y</forename><surname>Fonseka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Liu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">542</biblScope>
			<biblScope unit="page" from="110" to="114" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
